Torstein Øverland

  • PhD student MD
  • +47 23 07 39 03
 

Publications 2018

Aresvik DM, Øverland T, Lima K, Pettersen RD, Abrahamsen TG (2018)
Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome
J Clin Immunol, 39 (1), 65-74
DOI 10.1007/s10875-018-0579-7, PubMed 30569262

Publications 2016

Aresvik DM, Lima K, Øverland T, Mollnes TE, Abrahamsen TG (2016)
Increased Levels of Interferon-Inducible Protein 10 (IP-10) in 22q11.2 Deletion Syndrome
Scand J Immunol, 83 (3), 188-94
DOI 10.1111/sji.12406, PubMed 26708691

Sorte HS, Osnes LT, Fevang B, Aukrust P, Erichsen HC, Backe PH, Abrahamsen TG, Kittang OB, Øverland T, Jhangiani SN, Muzny DM, Vigeland MD, Samarakoon P, Gambin T, Akdemir ZH, Gibbs RA, Rødningen OK, Lyle R, Lupski JR, Stray-Pedersen A (2016)
A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction
Mol Genet Genomic Med, 4 (6), 604-616
DOI 10.1002/mgg3.237, PubMed 27896283

Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR et al. (2016)
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
J Allergy Clin Immunol, 139 (1), 232-245
DOI 10.1016/j.jaci.2016.05.042, PubMed 27577878

Publications 2015

Gul KA, Øverland T, Osnes L, Baumbusch LO, Pettersen RD, Lima K, Abrahamsen TG (2015)
Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features
J Clin Immunol, 35 (4), 408-15
DOI 10.1007/s10875-015-0153-5, PubMed 25814142

Publications 1989

OVERLAND T (1989)
CREATING A SUCCESSFUL MARKETING STRATEGY FOR UNI INSURANCE
Long Range Plan., 22 (4), 25-28

Page visits: 404